Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2006-03-28 (20 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: SAINT-GENIES-DE-MALGOIRES (30190), Gard
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DE SAINT GENIES DE MALGOIRES : revenue, balance sheet and financial ratios
PHARMACIE DE SAINT GENIES DE MALGOIRES is a French company
founded 20 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in SAINT-GENIES-DE-MALGOIRES (30190),
this company of category PME
shows in 2025 a net income positive of 134 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE SAINT GENIES DE MALGOIRES (SIREN 489530295)
Indicator
2025
2024
2023
2022
2021
2020
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
Net income
133 623 €
126 561 €
175 924 €
350 223 €
172 883 €
191 131 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE DE SAINT GENIES DE MALGOIRES generates positive net income of 134 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2020-2025: 191 k€ -> 134 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
133 623 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 36%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 64%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
35.716%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
63.513%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DE SAINT GENIES DE MALGOIRES
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2020
2021
2022
2023
2024
2025
Debt ratio
176.627
127.665
79.867
58.573
43.158
35.716
Financial autonomy
32.328
38.971
48.483
56.419
59.993
63.513
Repayment capacity
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
35.722025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Good-5 pts over 3 years
In 2025, the debt ratio of PHARMACIE DE SAINT GENIES... (35.72) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
63.51%2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Good
In 2025, the financial autonomy of PHARMACIE DE SAINT GENIES... (63.5%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 183.12. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
183.118
Liquidity indicators evolution PHARMACIE DE SAINT GENIES DE MALGOIRES
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2020
2021
2022
2023
2024
2025
Liquidity ratio
128.987
136.637
198.871
236.643
188.018
183.118
Interest coverage
None
None
None
None
None
None
Sector positioning
Liquidity ratio
183.122025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Good-14 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE DE SAINT GENIES... (183.12) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Positioning of PHARMACIE DE SAINT GENIES DE MALGOIRES in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE DE SAINT GENIES DE MALGOIRES is estimated at
2 122 617 €
(range 1 440 418€ - 3 330 678€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
1440k€2122k€3330k€
2 122 617 €Range: 1 440 418€ - 3 330 678€
NAF 5 année 2025
Valuation method used
Net Income Multiple
133 623 €
×
15.9x
=2 122 617 €
Range: 1 440 418€ - 3 330 679€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE SAINT GENIES DE MALGOIRES with other companies in the same sector:
Frequently asked questions about PHARMACIE DE SAINT GENIES DE MALGOIRES
What is the revenue of PHARMACIE DE SAINT GENIES DE MALGOIRES ?
The revenue of PHARMACIE DE SAINT GENIES DE MALGOIRES is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE DE SAINT GENIES DE MALGOIRES profitable?
Yes, PHARMACIE DE SAINT GENIES DE MALGOIRES generated a net profit of 134 k€ in 2025.
Where is the headquarters of PHARMACIE DE SAINT GENIES DE MALGOIRES ?
The headquarters of PHARMACIE DE SAINT GENIES DE MALGOIRES is located in SAINT-GENIES-DE-MALGOIRES (30190), in the department Gard.
Where to find the tax return of PHARMACIE DE SAINT GENIES DE MALGOIRES ?
The tax return of PHARMACIE DE SAINT GENIES DE MALGOIRES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE SAINT GENIES DE MALGOIRES operate?
PHARMACIE DE SAINT GENIES DE MALGOIRES operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart